Enbridge (NYSE:ENB) reported quarterly earnings of $0.67 per share which beat the analyst consensus estimate of $0.54 by 24.07 percent. This is a 24.07 percent increase over earnings of $0.54 per share from the same period last year.
Soleno Therapeutics Announces Initiation Of Randomized Withdrawal Study Of DCCR For Treatment Of Prader-Willi Syndrome
Soleno Therapeutics, Inc. (Soleno or the Company) (NASDAQ:SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that it has initiated a